Anti-NAP1L1 antibody [EPR11845]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal NAP1L1 antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
NRP, NAP1L1, Nucleosome assembly protein 1-like 1, NAP-1-related protein, hNRP
- WB
Supplier Data
Western blot - Anti-NAP1L1 antibody [EPR11845] (AB178687)
All lanes:
Western blot - Anti-NAP1L1 antibody [EPR11845] (ab178687) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Predicted band size: 45 kDa
false
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-NAP1L1 antibody [EPR11845] (AB178687)
Intracellular flow cytometric analysis of permeabilized 293T cells using ab178687 at a 1/10 dilution (red) or a rabbit IgG (negative) (green).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-NAP1L1 antibody [EPR11845] (AB178687)
Immunofluorescence analysis of HeLa cells labeling NAP1L1 with ab178687 at a 1/100 dilution. DAPI nuclear staining (blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NAP1L1 antibody [EPR11845] (AB178687)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling NAP1L1 with ab178687 at a 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-NAP1L1 antibody [EPR11845] (AB178687)
Western blot analysis on immunoprecipitation pellet from (Lane 1) 293T cell lysate or (Lane 2) 1X PBS (negative control) using ab178687 at a 1/10 dilution for IP and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
All lanes:
Immunoprecipitation - Anti-NAP1L1 antibody [EPR11845] (ab178687)
Predicted band size: 45 kDa
false
Related conjugates and formulations (1)
-
Anti-NAP1L1 antibody [EPR11845] - BSA and Azide free
Reactivity data
Product details
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NAP1L1 contributes to chromatin remodeling by facilitating the assembly and disassembly of nucleosomes. NAP1L1 forms part of a complex that modulates chromatin structure and function influencing gene expression and DNA replication. It interacts with histones contributing to the deposition and removal of histones H2A and H2B making it essential for proper cell cycle progression and regulation.
Pathways
NAP1L1 acts in key signaling interconnected with chromatin modification and cell cycle control. It participates in the histone chaperone pathways influencing chromatin structure dynamics. NAP1L1 associates with proteins like histone H2A-H2B and the chromatin assembly factor CAF-1. These proteins collectively maintain chromatin integrity and regulation during DNA replication and repair processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature structural & molecular biology 29:774-780 PubMed35915257
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Primary Antibodies
AB21630
Anti-NAP1L1 antibody
primary-antibodies
nap1l1-antibody-ab21630
5
(4 reviews)
Alternative Product
Primary Antibodies
AB174836
Anti-NAP1L1 antibody [EPR12619]
primary-antibodies
nap1l1-antibody-epr12619-ab174836
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com